Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTime Finance Regulatory News (TIME)

Share Price Information for Time Finance (TIME)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.75 (1.66%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £42.17m
TIME Live PriceLast checked at - London Stock Exchange

Intraday Time Finance Share Chart

Trading Update

17 Apr 2008 12:12

Timestrip PLC17 April 2008 TIME.L Timestrip plc ("Timestrip" of the Company") Trading Update The Company today announces a trading update in relation to its operationalperformance and its funding requirements and a proposed placing. Timestrip continues to increase its acceptance amongst its blue chip customerbase. Regular shipments of the Timestrip product are now being shipped to theCompany's largest customer, United Pet Group, under a 3 year contract expectedto generate sales of $3million over 3 years. Further, the Company isexperiencing increased repeat sales from existing customers. The Company has established a strong pipeline of potential contracts, whichgives the Directors optimism for the future and continues to pursue a strategyof licensing the rights to manufacture to third parties in local markets. Tothis end, the Company is engaged in discussions with interested parties in NorthAmerica and has recently acquired a third generation production machine tosatisfy the requirements of a licensee manufacturer. The Company has also recently reported that its second technology, the iStripfreeze monitor, is gaining wider distribution and acceptance in North Americaand Europe. It has been adopted by a leading pharmaceutical company inconnection with the storage of clinical trial materials and has already helpedidentify problems with shipments. The Company, in its interim statement in 28 September 2007, stated that itremained confident that it had adequate financial resource to reachprofitability. However, despite some material contract wins, this has notgenerated the immediate cash flows that had been hoped for and it is now clearthat further funding will be required to meet this objective. The Company, as atend of March 2008, had cash resources of £0.44 million which taking into accountvarious capital expenditure commitments provides funding for the currentoperations of the business until the end of May 2008, and has actively commenceda process of arranging an equity placing, which is likely to be at a discount tothe current price and is planned for completion early May 2008. For more information, please contact: Paul Freedman, Joint CEO, Timestrip plc 01462 440 700Shane Dolan, Biddicks 020 7448 1000Bobbie Hilliam, Evolution Securities 020 7071 4300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jun 20267:00 amRNSLending Book Milestone & Notice of Q4 Update
24th Mar 20267:00 amRNSQ3 Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
16th Mar 20267:00 amRNSNotice of Trading Update
27th Jan 20267:00 amRNSInterim Results
16th Dec 20257:00 amRNSHalf-Year Trading Update & Notice of Results
19th Nov 20257:00 amRNSGrant of 2025 LTIP Awards
14th Nov 20251:57 pmRNSExercise of Options & Director/PDMR Shareholdings
12th Nov 20257:00 amRNSLoan Book Update
6th Nov 202512:07 pmRNSResult of AGM
28th Oct 20257:00 amRNSNotice of Trading Update & Investor Presentations
3rd Oct 20257:00 amRNSVesting of Option Awards
26th Sep 20257:00 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSNotice of AGM
24th Sep 20257:01 amRNSQ1 Trading Update
24th Sep 20257:00 amRNSFinal Results
18th Sep 20257:00 amRNSNotice of Results, Investor Presentation and AGM
1st Aug 20257:00 amRNSExtended Funding Facilities
26th Jun 20257:00 amRNSTrading Update and Notice of Final Results
4th Jun 20257:00 amRNSLaunch of New Investor Hub
6th May 20257:00 amRNSNotice of Q4 Trading Update and of Final Results
25th Mar 20257:00 amRNSQ3 Trading Update
12th Mar 20257:00 amRNSNotice of Investor Presentation
3rd Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Feb 20257:00 amRNSDirector/PDMR Shareholding
27th Feb 202512:00 pmRNSNotice of Trading Update
11th Feb 20257:00 amRNSLending Portfolio Update
28th Jan 20257:00 amRNSInterim Results
19th Dec 20247:00 amRNSHalf-Year Trading Update & Notice of Results
22nd Nov 20249:03 amRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Update
5th Nov 202412:30 pmRNSResult of AGM
24th Oct 20247:00 amRNSExercise of Options & Director/PDMR Shareholdings
4th Oct 20247:00 amRNSVesting of Option Awards
3rd Oct 20247:00 amRNSDirector share purchases
2nd Oct 20247:00 amRNSExtended & Improved £65m NatWest Funding Facility
26th Sep 20247:00 amRNSNotice of AGM
25th Sep 20247:01 amRNSQ1 Trading Update
25th Sep 20247:00 amRNSFinal Results
10th Sep 20247:00 amRNSNotice of Results, Investor Pres & Trading Update
27th Aug 20247:00 amRNSGrowth Guarantee Scheme Accreditation
3rd Jul 20247:00 amRNSDirector Share Purchase
27th Jun 20247:00 amRNSTrading Update and Notice of Final Results
3rd Apr 20247:00 amRNSExtended & Improved £64m Funding Facility
26th Mar 20247:00 amRNSQ3 Trading Update
5th Mar 20247:00 amRNSNotice of Trading Update
25th Jan 20247:00 amRNSInterim Results
18th Jan 20244:30 pmRNSHolding(s) in Company
19th Dec 20237:00 amRNSHalf-Year Trading Update & Notice of Results
21st Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.